
Cardiovascular Disease Fellow @Tulane University 🎷• @floridastate alum • Made in 🇷🇸 #ACCFIT Leadership Council • https://xitter.cf/t.co/BMZxuzgump
New Orleans, LA
Joined January 2016
- Tweets1.6K
- Following3.2K
- Followers3.2K
- Likes14.2K
Pinned Tweet
📄 20 studies that Internal Medicine Residents should read in the first year 👇
1/ 🏃♀️ RACE II trial: Lenient resting HR < 110 was non-inferior to a strict HR < 80 in patients with atrial fibrillation.
🧵
📣Great opportunity for fellows! @SYSTOLE_live takes care of you!
Submit an abstract and receive complimentary registration, hotel accommodation and flight reimbursement! 😱
See you in Charlotte! #cardiotwitter #CorPhys2027 @SCAI @ACCinTouch
🏆 Best Abstract Competition | The U.S. Physiology Course 2027
Submit your best clinical case or original research in coronary physiology!
✓ Present before leading experts
✓ Complimentary registration & travel support
✓ Two awards
📅 Deadline: Dec 15, 2026
🔗 event.fourwaves.com/systole-…
#CorPhys2027
Stefan Milutinovic retweeted
これめっちゃスゴい!
さっきカテ室で技師さんに教えてもらったけど、
角度自分で調整して冠動脈造影どんなふうな見えるかわかる
カテ室にくる前に全研修医は確認必須!
今度からもうこのURL教えたらCAGの授業は完了
#循環器内科 #研修医
learncoronary.com
🖇️ is back!
Replying to @AhmedHassa43380 @OpenAI
It does now! The interest has been incredible, with over 1,000 visits per hour! 🔥As a fellow, I’m using the most affordable website hosting plan possible, so there might be a few occasional glitches here and there. Thanks for your patience!
Stefan Milutinovic retweeted
Congratulations @stefankmil for developing this incredible educational 🛠️to enhance ❤️learning!
I created LearnCoronary (learncoronary.com), an interactive tool designed to help general cardiology fellows and other early-career learners better understand coronary angiography and the spatial relationships between different angiographic views.
#cardiotwitter @OpenAI
📣 Excited to be an US Physiology Course Ambassador. Highly recommend registering for this hands-on course and learning directly from leaders in the field.
📅 Feb 1–2, 2027
📍 Charlotte, NC
🔗 Registration: event.fourwaves.com/systole-…
@yadersandoval @esbrilakis @ColletCarlos
🤖 Made with AI
Join us for The U.S. Physiology Course: 2nd Edition — an immersive, hands-on program in contemporary coronary physiology.
📅 Feb 1–2, 2027
📍 Charlotte, NC
🔗 Registration: event.fourwaves.com/systole-…
📧 [email protected]
Stefan Milutinovic retweeted
P4 is the first large RCT investigating the value of CT-guided PCI
We will present the results at the @TCTMD Late Breaking Clinical Trial session
@crfheart @GEHealthCare @Heartflow
🆕🔥🔥🔥The P4 randomised clinical trial evaluates whether a comprehensive CCTA-guided PCI strategy is non-inferior to IVUS-guided PCI for 12-month target vessel failure.
The CCTA strategy integrates anatomical and plaque assessment, FFRCT, virtual PCI planning, and intraprocedural CT-fluoroscopy co-registration.
🔗eurointervention.pcronline.c…
@bouissetfred @belmontemarta1 @ziadalinyc @SimoneBiscaglia @engstr_thomas @RajMakkarMD
@TheLADoctor @DrPeterOKane @divaka_perera @gpontone1 @yadersandoval @gmincione96 @GGStefanini @Eric_Van_Belle @DMunhoz @KoshiroSakai_MD @sbrugaletta @AIhdayhid @JonathonLeipsic @BernardBruyne @Ganeev @DAndreiniMD @ColletCarlos
26-year-old. Paradoxical embolism
in the setting of large ASD 😱 #cardiotwitter
Stefan Milutinovic retweeted
🚨 Now accepting applications for the CHIP/CTO Fellowship at Henry Ford Hospital! 🚨
Advanced training in complex high-risk PCI and chronic total occlusion interventions with a leading interventional cardiology team.
📅 Deadline: October 1st
Link 👇🏻
Stefan Milutinovic retweeted
International Day for Interventional Cardiology: the first coronary #angioplasty
On 16 September 1977, Andreas Grüntzig & his team made history, and changed the lives of millions of patients forever.
Standing on the shoulders of the giants that came before him, this transformative vision led to an entirely new field of medicine.
What began nearly five decades ago with coronary angioplasty has grown into the broad field of interventional cardiology, transforming cardiovascular care through research, innovation and technological progress.
As the field has evolved, so has the need to learn from experience, share knowledge and shape what comes next. Join us in 2027 at #EuroPCR to mark this landmark moment!
📅pcronline.com/Courses/EuroPC…
#medicalhistory #interventionalcardiologist #cathlab #cathlabteam
@NievesGonzalo1 @CuissetDr @nicolasdumonte1 @EmanueleBarba13
Stefan Milutinovic retweeted
Already, Russia and the Vucic co-opted security state are attempting to rig the October 25 election. Promulgating fake accounts, fake identities, propaganda, illicitly using state resources, and consolidating all media under state control. But we are watching! The Serbian people deserve fair and free elections.
Stefan Milutinovic retweeted
Can patient-facing AI improve hypertension control in underserved communities? LLMs offer great potential, but long-term success requires community partnership, clinical oversight, and rigorous implementation.
sciencedirect.com/science/ar…
#Cardio #AImedicine
Stefan Milutinovic retweeted
Less invasive does not always mean lower risk.
Our network meta-analysis of 19 RCTs, findings consistently favored carotid endarterectomy over carotid artery stenting and optimal medical therapy in both symptomatic and asymptomatic carotid stenosis.👇
sciencedirect.com/science/ar…
Stefan Milutinovic retweeted
Calling all cardiology fellows in southeast MI interested in CS/MCS management, please join us for a 1/2 half workshop at @BeaumontCards on Saturday Oct 3 from 7:30-1 pm. @RyanMadderMD @CanteyEric @DrJayMohan @LAuroraMD @AhmadJabri8 @AscensionM_CV @DBCardsFellows @waynecardio
Stefan Milutinovic retweeted
Novartis announces Lp(a)HORIZON Phase III topline results
“did not meet its primary endpoint”
There will be a lot to unpack here globenewswire.com/news-relea…
Stefan Milutinovic retweeted
🫀 Statins for primary prevention: 4 RCTs, 3 decades
AFCAPS→JUPITER→HOPE-3→STAREE
📉 24–44% ↓ major CV events
Even at baseline LDL (108 mg/dL)
No heterogeneity across subgroups in RRR
🟰 Safety ≈ placebo, few exceptions
⚖️ Benefits ≫ risks
💊 cost $30/year
Stefan Milutinovic retweeted
An incredible number of trials published simultaneously in the NEJM: I honestly can’t quite wrap my head around what is happening. Congratulations to everyone involved. It was difficult to choose only five trials, but these are the ones I selected for the interventional cardiology highlights. #ESCCongress































